Shenzhen - Delayed Quote CNY

Jiangsu Lanfeng Bio-chemical Co.,Ltd (002513.SZ)

4.9100
-0.0100
(-0.20%)
At close: 3:04:48 PM GMT+8
Currency in CNY All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,958,973.7813
1,793,141.0490
1,741,628.4072
1,445,239.9894
1,443,932.1448
Cost of Revenue
1,989,162.0248
1,831,504.3275
1,777,324.2751
1,435,811.3228
1,448,661.2959
Gross Profit
-30,188.2436
-38,363.2786
-35,695.8679
9,428.6665
-4,729.1511
Operating Expense
190,370.3307
197,725.0196
182,291.5688
119,281.7627
168,715.7783
Operating Income
-220,558.5742
-236,088.2982
-217,987.4367
-109,853.0961
-173,444.9294
Net Non Operating Interest Income Expense
-55,233.8526
-54,361.2566
-28,678.1730
-9,535.4944
-26,661.9645
Pretax Income
-416,374.6596
-434,835.5081
-354,333.0130
-246,968.6311
-538,860.3114
Tax Provision
-68,973.4609
-81,607.5214
-6,596.7768
73,723.8695
-47,668.3880
Net Income Common Stockholders
-244,145.6292
-252,500.7736
-332,260.4460
-320,692.4441
-491,191.9234
Basic EPS
-0.66
-0.68
-0.89
-0.86
-1.44
Diluted EPS
-0.66
-0.68
-0.89
-0.86
-1.44
Basic Average Shares
370,090.0110
368,668.0880
372,865.4990
373,941.7490
341,105.5020
Diluted Average Shares
370,090.0110
368,668.0880
372,865.4990
373,941.7490
341,105.5020
Total Operating Income as Reported
-389,248.7894
-403,597.1440
-346,671.8926
-180,460.0619
-531,809.4926
Total Expenses
2,179,532.3555
2,029,229.3472
1,959,615.8439
1,555,093.0855
1,617,377.0742
Net Income from Continuing & Discontinued Operation
-244,145.6292
-252,500.7736
-332,260.4460
-320,692.4441
-491,191.9234
Normalized Income
-141,731.5116
-153,288.1018
-201,466.8552
-271,096.5868
-189,114.1497
Interest Income
6,887.5845
6,970.3775
1,010.5151
7,755.5752
2,230.8963
Interest Expense
60,131.7987
59,531.5749
26,533.9454
13,554.5111
22,597.8030
Net Interest Income
-55,233.8526
-54,361.2566
-28,678.1730
-9,535.4944
-26,661.9645
EBIT
-356,242.8609
-375,303.9332
-327,799.0676
-233,414.1200
-516,262.5084
EBITDA
-356,242.8609
-251,952.9564
-229,577.9587
-137,599.3278
-399,899.5559
Reconciled Cost of Revenue
1,989,162.0248
1,831,504.3275
1,777,324.2751
1,435,811.3228
1,448,661.2959
Reconciled Depreciation
--
123,350.9768
98,221.1090
95,814.7922
116,362.9525
Net Income from Continuing Operation Net Minority Interest
-244,145.6292
-252,500.7736
-332,260.4460
-320,692.4441
-491,191.9234
Total Unusual Items Excluding Goodwill
-122,747.5424
-122,134.1291
-133,274.8281
-66,127.8097
-331,393.3219
Total Unusual Items
-122,747.5424
-122,134.1291
-133,274.8281
-66,127.8097
-331,393.3219
Normalized EBITDA
-233,495.3185
-129,818.8272
-96,303.1306
-71,471.5181
-68,506.2340
Tax Rate for Calcs
0.0002
0.0002
0
0.0003
0.0001
Tax Effect of Unusual Items
-20,333.4248
-22,921.4574
-2,481.2373
-16,531.9524
-29,315.5482
12/31/2021 - 12/3/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Waiting for permission
Allow microphone access to enable voice search

Try again.